公司资料
Surface Oncology 股价、新闻与催化剂
- 股票代码:
- SURF
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for SURF.
公司概览
业务概览
Surface Oncology was an immuno-oncology company focused on antibody-based cancer therapies before its restructuring and decline. Its platform centered on immune checkpoints and tumor biology.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ before restructuring, Surface sat in oncology biotechnology.
商业模式特征
The business depended on clinical validation, platform differentiation, and the ability to create oncology value.
生物医药行业定位
Surface belongs to the historical oncology-biotech category rather than the current live public-company set.
未来催化剂
- Surface Oncology is now largely a closeout story, with catalysts limited to any strategic or asset-disposition update. Investors are mainly watching what residual value can be realized.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。